SLC5A2 and bacterial urinary tract infection: After first UTI, 63.5% of patients continued SGLT2i treatment, 9.82% discontinued SGLT2 inhibitors, 26.68% received SGLT2i rechallenge. 23/438 UTI patients needed IV antibiotics.